Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Dermatitis atopic · Cancer

Sanofi-Aventis U.S

Sanofi-aventis Healthcare Pty Ltd

Sanofi-Aventis U.S trial registry — 117 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
Bridgewater, USA HQ
177 Employees
TGA registrant Type
Company details
Status
Public
HQ
Bridgewater, USA
Employees
177
Programs
117
Drugs
148
Patents
0
Official website ↗ All projects Drug pipeline News & analysis
Intelligence · Clinical Trials

Sanofi-Aventis U.S clinical trials

Registry index of 117 ClinicalTrials.gov studies linked to Sanofi-Aventis U.S programs — each row shows trial ID, program name, phase, status, and indication.

Sanofi-Aventis U.S trial registry — 117 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Sanofi-Aventis U.S.

  1. SAD18184/MAD18185 — Phase 1

    Clinical update

  2. PSK00010 — Phase 3

    Clinical update

  3. PKM23567 — Phase 1

    Clinical update

  4. PDY17892 — Phase 1

    Clinical update

  5. EFC17872 — Phase 3

    Clinical update

  6. EFC17360 - LUMINA 3 — Phase 3

    Clinical update

  7. DRI18180 — Phase 2

    Clinical update

  8. DRI17963 — Phase 2

    Clinical update

Trial registry

117 studies
  31. 2023-508357-58-00

    TCD17197

    Phase 2 active small_molecule

    Acute lymphocytic leukaemia- Acute myeloid leukaemia refractory - Myelodysplastic syndrome - Blastic plasmacytoid dendritic cell neoplasia

    CTIS ↗

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.